Relevant bibliographies by topics / Pharmacovigilance in dermatology

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters

Academic literature on the topic 'Pharmacovigilance in dermatology'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmacovigilance in dermatology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmacovigilance in dermatology"

1

Lebwohl, Mark, Andrea Murina, George Han, and Abby Jacobson. "Brodalumab: 4-Year US Pharmacovigilance Report." SKIN The Journal of Cutaneous Medicine 7, no. 2 (2023): s132. http://dx.doi.org/10.25251/skin.7.supp.132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Garcia‐Doval, I., E. Segovia, H. Hunter, J. Frew, and L. Naldi. "The value of case reports in pharmacovigilance." British Journal of Dermatology 183, no. 5 (2020): 795–96. http://dx.doi.org/10.1111/bjd.19504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schmutz, J. L. "Alitrétinoïne (Toctino®) : données récentes de pharmacovigilance." Annales de Dermatologie et de Vénéréologie 147, no. 4 (2020): 329–30. http://dx.doi.org/10.1016/j.annder.2020.01.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bettuzzi, Thomas, Aaron Drucker, Delphine Staumont-Sallé, Kevin Bihan, Bénédicte Lebrun-Vignes, and Emilie Sbidian. "34927 Adverse events associated with dupilumab in the WHO pharmacovigilance." Journal of the American Academy of Dermatology 87, no. 3 (2022): AB136. http://dx.doi.org/10.1016/j.jaad.2022.06.578.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Khopkar, Uday. "Reporting of drug eruptions: The national pharmacovigilance program." Indian Journal of Dermatology, Venereology and Leprology 71, no. 1 (2005): 1. http://dx.doi.org/10.4103/0378-6323.13776.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

International, Journal of Medical Science and Advanced Clinical Research (IJMACR). "Evaluation of Adverse Drug Reactions in Outpatients and Inpatients in Department of Dermatology at Tertiary Care Hospital." International Journal of Medical Science and Advanced Clinical Research (IJMACR) 8, no. 2 (2025): 20–28. https://doi.org/10.5281/zenodo.15239868.

Full text
Abstract:
<strong>Abstract</strong> <strong>Objective: </strong>The study aims to evaluate the clinical spectrum, morphology, and causative drugs responsible for CADRs in inpatients and outpatients attending the dermatology department of a tertiary care center. It also emphasizes the necessity of an effective pharmacovigilance system to improve drug safety and minimize CADR-related morbidity and mortality. <strong>Methods</strong>: A cross-sectional observational study was conducted at a tertiary care center in Jamnagar, Gujarat, from January 2023 to June 2024. A total of 150 patients presenting with CA
APA, Harvard, Vancouver, ISO, and other styles
7

Paul, C. "Science, marketing et pharmacovigilance : l’exemple des inhibiteurs topiques de la calcineurine." Annales de Dermatologie et de Vénéréologie 134, no. 11 (2007): 817–21. http://dx.doi.org/10.1016/s0151-9638(07)92823-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

CASTRO, Clarisse F., Cesar A. TEIXEIRA, Nurimar C. FERNANDES, and Guacira C. MATOS. "Severe cutaneous adverse reactions to drugs: a case series study." Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde 11, no. 3 (2020): 471. http://dx.doi.org/10.30968/rbfhss.2020.113.0471.

Full text
Abstract:
Objective: to describe five cases of severe cutaneous adverse reactions to drugs (SCARD) that led to hospitalization and were investigated and diagnosed by the dermatology service of a university hospital. Methods: this is a descriptive observational study of the case series type in which were included patients aged 18 years old or older from both sexes, hospitalized between January 2015 and July 2019, in a university hospital in Rio de Janeiro, Brazil and whose reason for hospitalization was SCARD diagnosed by the dermatology service. For SCARD causality assessments, two internationally adopt
APA, Harvard, Vancouver, ISO, and other styles
9

Pelet del Toro, Natalia, Andrew Strunk, Jashin Wu, et al. "Topical Clindamycin For Acne Vulgaris: Pharmacovigilance Safety Review and Retrospective Analysis of Gastrointestinal Events." SKIN The Journal of Cutaneous Medicine 8, no. 1 (2024): s341. http://dx.doi.org/10.25251/skin.8.supp.341.

Full text
Abstract:
Background: Clindamycin, a lincosamide antibiotic, was the 125th most prescribed medicine in the US in 2020. Topical formulations that combine clindamycin with benzoyl peroxide or a retinoid are commonly used for acne vulgaris (AV) treatment. While oral and topical clindamycin carry warnings/contraindications regarding the development of gastrointestinal (GI) adverse events (AEs), the real-world incidence of these AEs with topical clindamycin is unknown. The objective is to provide an overview of safety data for topical clindamycin when used for AV treatment.&#x0D; Methods: Safety data from pu
APA, Harvard, Vancouver, ISO, and other styles
10

Pelet del Toro, Natalia, Andrew Strunk, Jashin Wu, et al. "Topical Clindamycin For Acne Vulgaris: Pharmacovigilance Safety Review and Retrospective Analysis of Gastrointestinal Events." SKIN The Journal of Cutaneous Medicine 8, no. 1 (2024): s356. http://dx.doi.org/10.25251/skin.8.supp.356.

Full text
Abstract:
Background: Clindamycin, a lincosamide antibiotic, was the 125th most prescribed medicine in the US in 2020. Topical formulations that combine clindamycin with benzoyl peroxide or a retinoid are commonly used for acne vulgaris (AV) treatment. While oral and topical clindamycin carry warnings/contraindications regarding the development of gastrointestinal (GI) adverse events (AEs), the real-world incidence of these AEs with topical clindamycin is unknown. The objective is to provide an overview of safety data for topical clindamycin when used for AV treatment.&#x0D; Methods: Safety data from pu
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pharmacovigilance in dermatology"

1

Paultre-Béliveau, Solange. "Dermatovigilance hospitalière chez les enfants de 0 à 4 ans." Thèse, 2003. http://hdl.handle.net/1866/14167.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pharmacovigilance in dermatology"

1

Kalb, Robert E. "Pharmacovigilance." In Biologic and Systemic Agents in Dermatology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66884-0_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kumar, Rishi, V. Kalaiselvan, and G. N. Singh. "Topical Corticosteroids: The Pharmacovigilance Perspective." In A Treatise on Topical Corticosteroids in Dermatology. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4609-4_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gelfand, Joel M., and Megan H. Noe. "Pharmacovigilance." In Comprehensive Dermatologic Drug Therapy. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-323-61211-1.00007-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gelfand, Joel M., and Sinéad M. Langan. "Pharmacovigilance." In Comprehensive Dermatologic Drug Therapy. Elsevier, 2013. http://dx.doi.org/10.1016/b978-1-4377-2003-7.00006-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pharmacovigilance in dermatology' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography